LRMR - Larimar Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.00
DETAILS
HIGH:
$12.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$12.00
UPSIDE:
247.83%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-19 | SHERMAN JEFFREY W | director | A-Award | 55,150 | $3.33 | $184K |
| 2026-05-19 | Truitt Joseph | director | A-Award | 55,150 | $3.33 | $184K |
| 2026-05-19 | THOMAS FRANK E | director | A-Award | 55,150 | $3.33 | $184K |
| 2026-05-19 | Hamilton Thomas Edward | director | A-Award | 55,150 | $3.33 | $184K |
| 2026-05-19 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | A-Award | 55,150 | $3.33 | $184K |
| 2026-05-19 | LEFF JONATHAN S | director | A-Award | 55,150 | $3.33 | $184K |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 1,084,010 | $5.00 | $5.4M |
| 2026-02-27 | SHERMAN JEFFREY W | director | BUY | 5,000 | $5.00 | $25K |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 1,084,012 | $5.00 | $5.4M |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 831,978 | $5.00 | $4.2M |
| 2026-02-27 | THOMAS FRANK E | director | BUY | 5,000 | $5.00 | $25K |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 2,000,000 | $5.00 | $10.0M |
| 2026-02-27 | Hamilton Thomas Edward | director | BUY | 100,000 | $5.00 | $500K |
| 2026-01-26 | Shankar Gopi | officer: Chief Development Officer | A-Award | 153,822 | $3.60 | $554K |
| 2026-01-26 | Shankar Gopi | officer: Chief Development Officer | A-Award | 25,637 | -- | -- |
| 2026-01-26 | Clayton Russell | officer: Chief Medical Officer | A-Award | 153,822 | $3.60 | $554K |
| 2026-01-26 | Clayton Russell | officer: Chief Medical Officer | A-Award | 25,637 | -- | -- |
| 2026-01-26 | Celano Michael | officer: Chief Financial Officer | A-Award | 225,622 | $3.60 | $812K |
| 2026-01-26 | Celano Michael | officer: Chief Financial Officer | A-Award | 37,604 | -- | -- |
| 2026-01-26 | BEN-MAIMON CAROLE | director, officer: President and CEO | A-Award | 600,600 | $3.60 | $2.2M |
| 2026-01-26 | BEN-MAIMON CAROLE | director, officer: President and CEO | A-Award | 100,100 | -- | -- |
| 2025-07-31 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 2,599,932 | $3.20 | $8.3M |
| 2025-07-31 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 3,387,539 | $3.20 | $10.8M |
| 2025-07-31 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | BUY | 3,387,529 | $3.20 | $10.8M |
| 2025-05-13 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | A-Award | 19,000 | $1.88 | $36K |